Akeso Inc. (9926.HK) ("Akeso", "the Company") released its 2024 annual report, emphasizing the company's key achievements in drug research, clinical development, and commercialization. In 2024, Akeso ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback